Biosyent Inc (RX)

[valuemind]

Mr. Montador may mean a lot to Biosyent Inc.:

In 2008, CryoCath Technologies Inc. with annual revenue $40 million was acquired by Medtronic, Inc. for $400 million. At that time, Mr. Montador was a board member there. Now he became the board member of BioSyent Inc. Assume 40% annual revenue growth rate in the next 7 years, BioSyent Inc. will have annual revenue over $40 million by 2018. The headline in 2018 could be that "BioSyent Inc. with annual revenue $40 million was acquired by xxx for $400 million".